APIs
Qilu has very strong track records in the regulatory filings. We have applied over 50 USDMFs, over 40 CEPs, over 20 JDMFs and hundreds of registrations in other countries. over 20 APIs hold the world’s largest market share.
Abiraterone Acetate
Bortezomib
Capecitabine
Carboplatin
Cisplatin
Docetaxel Anhydrous
Docetaxel Trihydrate
Exemestane
Gefitinib
Gemcitabine Hydrochloride
Hydroxyurea
Imatinib Mesylate
Irinotecan Hydrochloride
Oxaliplatin
Pemetrexed Disodium
Sorafenib Tosylate
Tegafur
Fosaprepitant Dimeglumine
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail:export@qilu-pharma.com, FDF@qilu-pharma.com
监督举报
亲爱的合作伙伴:
欢迎举报以下行为!
索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。
举报电话:0531-83126898/55820713/83126871
举报邮箱:qljc@qilu-pharma.com
收信地址:山东省济南市历城区旅游路8888号
齐鲁制药集团审计监察部
采购平台技术专线